Co-portfolio manager of Fidelity European Fund and Fidelity European Trust PLC
Read BioMarkets have been given renewed impetus from China’s re-opening and corporate results above expectations, despite heightened levels of macro uncertainty. In this session, Marcel will review the current opportunity set across continental Europe - a region which is home to some great companies with global revenues. Within this, he will discuss the benefits of investing in resilient businesses that are able to consistently grow their dividends to shareholders.
Companies with pricing power lie at the heart of this as inflationary pressures persist. Marcel will highlight examples of companies that have pricing power by virtue of them producing products with inelastic demand, operating in small but critical niches, or having an unassailable competitive position. He will also outline why the recent strong performance of European equities versus other markets could still have some way to go, with the recovery staged so far doing little to reverse the underperformance seen post-global financial crisis.
View PDFIn this session, Rosanna Burcheri & Ashish Bhardwaj will take a deep dive into the investment philosophy and process that underpins the Fidelity American Special Situations Fund. Within this, they will examine the outlook for value investing in the current environment and highlight how a strong focus on quality companies trading at attractive valuations, supported by long term tailwinds, can produce attractive long-term returns for investors.
View PDF